| Line item | 2026-03-31 FY | 2025-03-31 FY | 2024-03-31 FY | 2023-03-31 FY | 2022-03-31 FY |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $27.06K | $27.85K | $46.32K | $21.50K | – |
| R&D | – | – | – | – | – |
| SG&A | $0.00 | $8.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | -$27.06K | -$27.85K | -$46.32K | -$21.50K | -$19.68K |
| Interest Expense | $627.00 | $116.00 | $0.00 | – | – |
| Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$27.06K | -$27.85K | -$44.16K | -$21.50K | -$19.68K |
| EPS (basic) | – | – | – | – | – |
| EPS (diluted) | 0.0000 | 0.0000 | 0.0000 | – | – |
| Shares (diluted) | $242.67M | $262.34M | $248.02M | – | – |